Physician profile
Kiwon Lee
NPI 1710908322
$7,378.56
in general payments reported to CMS, 2019-2025
9 companies · $596 in 2025
The $596 reported for 2025 was more than what a typical Vascular Neurology provider received nationally (typical 2025 total: $360).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $340 · 2020: $3,790 · 2021: $2,415 · 2022: $135 · 2024: $102 · 2025: $596.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $698.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $698.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $5,721.98 | 2020-2025 | Nayzilam |
| Btg International INC. | $676.33 | 2024-2025 | |
| Alexion Pharmaceuticals, INC. | $363.67 | 2021-2022 | |
| La Jolla Pharmaceutical Company | $209.11 | 2019 | |
| Stryker Corporation | $115.29 | 2019 | |
| Chiesi USA, INC. | $95.92 | 2020 | |
| Medtronic USA, INC. | $93.63 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $86.69 | 2021 | |
| Portola Pharmaceuticals, LLC | $15.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kiwon Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.